Segue abaixo resumo de um dos trabalhos elaborados pela equipe do CIEM apresentados no BCTRIMS 2015:
The most effective treatment of disease activity in multiple sclerosis (MS) may be a key factor in prevention of an unfavorable outcome, particularly in the early phases of the disease. Early identification of failure of disease-modifying therapies (DMT) may prompt appropriate medical intervention providing patients with the best available care. As MS treatment is rapidly evolving and new drugs are added to therapeutic armamentarium, clinicians face, on the other hand, a more complex scenario to take decisions and make choices.
A specific MS Outpatient Clinic with focus on treatment failure – the MS Suboptimal Treatment Outpatient Clinic – was then set at CIEM MS Research Center of the Federal University of MInas Gerais Medical School to see patients in whom disease activity has been identified in spite of use of DMT.